BlackRock’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.9M | Sell |
17,035,535
-1,033,747
| -6% | -$3.51M | ﹤0.01% | 2330 |
|
|
2025
Q1 | $72.5M | Sell |
18,069,282
-413,513
| -2% | -$1.66M | ﹤0.01% | 2164 |
|
|
2024
Q4 | $120M | Sell |
18,482,795
-9,496
| -0.1% | -$61.6K | ﹤0.01% | 1951 |
|
|
2024
Q3 | $102M | Buy |
18,492,291
+1,421,869
| +8% | +$7.88M | ﹤0.01% | 2051 |
|
|
2024
Q2 | $95.3M | Sell |
17,070,422
-355,549
| -2% | -$1.98M | ﹤0.01% | 2041 |
|
|
2024
Q1 | $117M | Sell |
17,425,971
-353,782
| -2% | -$2.37M | ﹤0.01% | 1943 |
|
|
2023
Q4 | $162M | Buy |
17,779,753
+1,009,080
| +6% | +$9.2M | ﹤0.01% | 1766 |
|
|
2023
Q3 | $92.6M | Buy |
16,770,673
+1,643,168
| +11% | +$9.07M | ﹤0.01% | 2013 |
|
|
2023
Q2 | $129M | Buy |
15,127,505
+6,840,258
| +83% | +$58.4M | ﹤0.01% | 1859 |
|
|
2023
Q1 | $76.2M | Sell |
8,287,247
-80,360
| -1% | -$739K | ﹤0.01% | 2163 |
|
|
2022
Q4 | $85.4M | Buy |
8,367,607
+449,965
| +6% | +$4.59M | ﹤0.01% | 2088 |
|
|
2022
Q3 | $117M | Buy |
7,917,642
+780,250
| +11% | +$11.5M | ﹤0.01% | 1852 |
|
|
2022
Q2 | $76.6M | Buy |
7,137,392
+1,044,052
| +17% | +$11.2M | ﹤0.01% | 2180 |
|
|
2022
Q1 | $65.7M | Buy |
6,093,340
+3,722,881
| +157% | +$40.1M | ﹤0.01% | 2384 |
|
|
2021
Q4 | $38.7M | Buy |
2,370,459
+515,716
| +28% | +$8.42M | ﹤0.01% | 2790 |
|
|
2021
Q3 | $39.7M | Buy |
+1,854,743
| New | +$39.7M | ﹤0.01% | 2779 |
|